Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Transdermal Drug Delivery Systems01:18

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preoperative Use of Venoarterial Extracorporeal Membrane Oxygenation in Postinfarct Ventricular Septal Rupture: Insights From the Extracorporeal Life Support Organization Registry.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

The Clinical Impact of Concomitant Hemi-Arch Reconstruction at the time of Aortic Root Replacement.

JTCVS open·2026
Same author

No-touch versus conventional vein harvesting in coronary bypass surgery: A meta-analysis of randomized controlled trials.

JTCVS open·2026
Same author

Aortic root replacement after repaired congenital conotruncal defects: A surgical challenge.

JTCVS open·2026
Same author

Optimal strategy for aortic root replacement in patients of advanced age: Valve-sparing root replacement or Bio-Bentall?

The Journal of thoracic and cardiovascular surgery·2026
Same author

Free Versus In situ Right Internal Mammary Artery as a Conduit in Coronary Artery Bypass Surgery: A Meta-Analysis.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same journal

The Heart-Brain Connection.

Cardiology clinics·2026
Same journal

Overcoming Psychological Barriers to Treatment Adherence: The Case of Antihypertensive Medication.

Cardiology clinics·2026
Same journal

Cardio-oncology Rehabilitation and Mental Health: Current Evidence and Future Perspectives.

Cardiology clinics·2026
Same journal

Cardiac Rehabilitation and Mental Health.

Cardiology clinics·2026
Same journal

Best-Practice Mental Health Interventions Following Acute Cardiovascular Events.

Cardiology clinics·2026
Same journal

Positive Psychology Interventions and Cardiovascular Health: Frequency and Duration to Sustain Cardiovascular Benefits.

Cardiology clinics·2026
See all related articles

Related Experiment Video

Updated: May 27, 2026

Home-Based Transcranial Direct Current Stimulation Device Development: An Updated Protocol Used at Home in Healthy Subjects and Fibromyalgia Patients
11:26

Home-Based Transcranial Direct Current Stimulation Device Development: An Updated Protocol Used at Home in Healthy Subjects and Fibromyalgia Patients

Published on: July 14, 2018

Current technology: devices available for destination therapy.

Hiroo Takayama1, Jonathan A Yang, Yoshifumi Naka

  • 1Department of Surgery, Columbia University Medical Center, Milstein Hospital Building, New York, NY 10032, USA.

Cardiology Clinics
|November 9, 2011
PubMed
Summary
This summary is machine-generated.

Continuous flow devices represent a significant advancement in destination therapy for end-stage heart failure. Midterm results suggest no adverse impact on end-organ function, though further research into complications is needed.

More Related Videos

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project
06:52

The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project

Published on: November 12, 2009

Related Experiment Videos

Last Updated: May 27, 2026

Home-Based Transcranial Direct Current Stimulation Device Development: An Updated Protocol Used at Home in Healthy Subjects and Fibromyalgia Patients
11:26

Home-Based Transcranial Direct Current Stimulation Device Development: An Updated Protocol Used at Home in Healthy Subjects and Fibromyalgia Patients

Published on: July 14, 2018

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project
06:52

The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project

Published on: November 12, 2009

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Management

Background:

  • End-stage heart failure presents significant challenges for patient management.
  • Left ventricular assist devices (LVADs) are increasingly utilized for destination therapy.
  • Continuous flow (CF) LVADs represent a technological advancement over previous models.

Purpose of the Study:

  • To evaluate the impact of continuous flow LVADs as destination therapy for end-stage heart failure.
  • To assess the midterm effects of CF LVADs on end-organ function.
  • To identify and discuss complications associated with CF LVAD technology.

Main Methods:

  • Review of existing literature and clinical data on continuous flow LVADs.
  • Analysis of patient outcomes, focusing on end-organ function and device-related complications.
  • Midterm follow-up assessments of patients receiving LVAD destination therapy.

Main Results:

  • Continuous flow LVADs have significantly advanced destination therapy options.
  • Midterm data indicate no detrimental effects on end-organ function with CF LVADs.
  • A range of expected and unexpected complications have been reported with this technology.

Conclusions:

  • Continuous flow LVADs are a promising option for destination therapy in end-stage heart failure.
  • Further clinical experience and research are essential to fully understand and manage complications.
  • Long-term outcomes and safety profiles require continued investigation.